Avaliação econômica do tratamento do glaucoma primário de ângulo aberto no Brasil: um estudo de custo-utilidade sob a perspectiva da sociedade
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Glaucoma is a chronic disease and its predominant type, primary open-angle
glaucoma, is genetic, so its primary prevention is still infeasible in practice.Key actions
to slow the spread of the disease are focused on early diagnosis and effective
treatment. Treatment and control of the disease can be done through surgery, laser or
eye drops. With the aging of the world population and the increasing costs of treating
glaucoma, a cost-effective allocation of resources is necessary in the treatment and
control of primary open-angle glaucoma. The objective of this study is to evaluate the
comparative efficiency of the treatment of primary open angle glaucoma in Brazil, by
evaluating the cost-utility of several treatment strategies taking into account the direct
and indirect costs. The cost-utility study was based on the Markov model. Three
treatment strategies were tested: no treatment, initial treatment with eye drops and
initial treatment with laser trabeculoplasty. The measure of outcome was the
incremental cost-utility ratio and the robustness of the model was tested through
sensitivity analysis. Of the strategies tested, the initial treatment with eye drops was
the most cost-effective and dominant over the others. It was concluded that both laser
trabeculoplasty and medications as primary treatments of primary open-angle
glaucoma generated significant gains in quality of life. The initial treatment alternative
through laser trabeculoplasty was not cost-effective.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

